New Key Statistics Module, Z-Score and F-Score
NYSE:NUVB Key Ratios
Market Cap $ M | 661.24 |
Enterprise Value $ M | 34.29 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 0.97 |
Price/Sales | -- |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | -- |
EPS (TTM) $ | -0.35 |
Beneish M-Score | 0 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -0.34 |
EV-to-EBITDA | -0.34 |
PEG | -- |
Shares Outstanding M | 246.73 |
Net Margin (%) | -- |
Operating Margin % | -- |
Pre-tax Margin (%) | -- |
Quick Ratio | 44.11 |
Current Ratio | 44.11 |
ROA % (ttm) | -11.76 |
ROE % (ttm) | -12.08 |
ROIC % (ttm) | -1,246.84 |
Dividend Yield % | -- |
Altman Z-Score | -- |
Piotroski F-Score | 3.00 |
Positive ROA | N |
Positive CFROA | N |
Higher ROA y-y | Y |
Cash flow > Earnings | Y |
Lower Leverage y-y | Y |
Higher Current Ratio y-y | N |
Less Shares Outstanding y-y | N |
Gross Margin Increase y-y | N |
Higher Asset Turnover y-y | N |
NUVB Number of Guru Trades
NUVB Volume of Guru Trades
Gurus Latest Trades with NYSE:NUVB
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NYSE:NUVB is held by these investors
Total 1
Nuvation Bio Inc Insider Transactions
No Available Data
News about NYSE:NUVB
Total 0- 1